Accuracy of in vitro susceptibility tests for carbapenemase-producing Gram-negative bacteria

References

1. Bulik C. C., Fauntleroy K. A., Jenkins S. G., Abuali M., LaBombardi V. J., Nicolau D. P., Kuti J. L. 2010; Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J Clin Microbiol 48:2402–2406 [View Article][PubMed]
   [Google Scholar]
2. Carmeli Y., Akova M., Cornaglia G., Daikos G. L., Garau J., Harbarth S., Rossolini G. M., Souli M., Giamarellou H. 2010; Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 16:102–111 [CrossRef]
   [Google Scholar]
3. CLSI 2012 Performance Standards for Antimicrobial Susceptibility Testing 22nd Informational Supplement M100-S22 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
4. CLSI 2015 Performance Standards for Antimicrobial Susceptibility Testing 25th Informational Supplement M100-S25 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Doern C. D., Dunne W. M. Jr, Burnham C. A. 2011; Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. J Clin Microbiol 49:1143–1147 [View Article][PubMed]
   [Google Scholar]
6. Espedido B. A., Thomas L. C., Iredell J. R. 2007; Metallo-β-lactamase or extended-spectrum β-lactamase: a wolf in sheep's clothing. J Clin Microbiol 45:2034–2036 [View Article][PubMed]
   [Google Scholar]
7. Giakkoupi P., Tzouvelekis L. S., Daikos G. L., Miriagou V., Petrikkos G., Legakis N. J., Vatopoulos A. C. 2005; Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J Clin Microbiol 43:494–496 [View Article][PubMed]
   [Google Scholar]
8. Kollef K. E., Schramm G. E., Wills A. R., Reichley R. M., Micek S. T., Kollef M. H. 2008; Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria. Chest 134:281–287 [View Article][PubMed]
   [Google Scholar]
9. Queenan A. M., Bush K. 2007; Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440–458 [View Article][PubMed]
   [Google Scholar]
10. Sabuda D. M., Laupland K., Pitout J., Dalton B., Rabin H., Louie T., Conly J. 2008; Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa . Can J Infect Dis Med Microbiol 19:413–418
    [Google Scholar]
11. Souli M., Kontopidou F. V., Papadomichelakis E., Galani I., Armaganidis A., Giamarellou H. 2008; Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek University Hospital. Clin Infect Dis 46:847–854 [View Article][PubMed]
    [Google Scholar]
12. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E. M., Posteraro B., Fiori B., Citton R., D'Inzeo T., Fadda G., other authors. 2007; Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994 [View Article][PubMed]
    [Google Scholar]
13. Woodford N., Eastaway A. T., Ford M., Leanord A., Keane C., Quayle R. M., Steer J. A., Zhang J., Livermore D. M. 2010; Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae . J Clin Microbiol 48:2999–3002 [View Article][PubMed]
    [Google Scholar]
14. Zavascki A. P., Barth A. L., Gonçalves A. L., Moro A. L., Fernandes J. F., Martins A. F., Ramos F., Goldani L. Z. 2006; The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58:387–392 [View Article][PubMed]
    [Google Scholar]